Buy Cardano While Whales Continue to Accumulate Bitcoin

by

InvestorPlace – Stock Market News, Stock Advice & Trading Tips Bitcoin (CCC:BTC-USD), and cryptos in general, have been stuck in a sideways trading pattern lately. They have strong resistance, but they also have strong support. Source: Shutterstock This makes now as good a time as any to accumulate. Because when this sideways pattern ends, it’ll … Read more

Ubisoft Announces New Lineup

by

SINGAPORE, June 13, 2021 /PRNewswire/ — Today, during Ubisoft Forward, Ubisoft announced six new game titles that will be released in 2021/2022: Riders Republic™, Tom Clancy’s Rainbow Six® Extraction, Far Cry® 6, Just Dance®2022, Rocksmith™+, and Mario + Rabbids® Sparks of Hope. These new games will be available on various gaming platforms and suit a multitude … Read more

A venture capital firm that only invests in space is going public so retail investors can take a shot at backing the next Elon Musk

by

Private investment into the commercial space industry is booming, topping $8.9 billion last year. CC Yuzhny/Rocosmos Venture capital firm Seraphim Capital is, unusually, planning to IPO and aims to raise $211 million. The space-focused fund wants to capitalize on the excitement around commercial space. Entrepreneurs like Elon Musk, Jeff Bezos, and Richard Branson are all … Read more

Daiki Axis Co., Ltd. (4245, First Section, Tokyo Stock Exchange) Overview of Operating Performance for the First Three Months Ended March 31, 2021

by

TOKYO, June 11, 2021 /PRNewswire/ — In the three months ended March 31, 2021, net sales increased while profit declined. Meanwhile, the Company has formulated its new medium-term management plan, “PROTECT × CHANGE” and is proceeding with its corporate mission of “Protecting the environment and changing the future.” Summary of Results The business environment surrounding … Read more

European Hematology Association – Pegcetacoplan Maintains a Durable Response in Patients with Paroxysmal Nocturnal Hemoglobinuria Through Week 48

by

THE HAGUE, Netherlands, June 12, 2021 /PRNewswire/ — The PEGASUS phase-3 study previously demonstrated that pegcetacoplan, a drug controlling intra- and extravascular hemolysis, was superior to eculizumab in patients with paroxysmal nocturnal hemoglobinuria at the week 16 endpoint of the randomized controlled period (RCP). After week 16, patients entered an open-label period where all patients … Read more

European Hematology Association- First-Line Ibrutinib + Venetoclax Is Superior to Chlorambucil + Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocyte Lymphoma

by

THE HAGUE, Netherlands, June 12, 2021 /PRNewswire/ – The combination of ibrutinib and venetoclax may be effective for treating patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) due to the complementary mechanisms of action of the two targeted therapies. Ibrutinib mobilizes CLL cells from the lymph nodes and inhibits cancer cell proliferation while venetoclax kills … Read more

European Hematology Association: Overall Survival Benefit Established With Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) in Elderly Patients with Transplant-ineligible Newly Diagnosed Mul…

by

THE HAGUE, Netherlands, June 12, 2021 /PRNewswire/ — The phase 3 MAIA study evaluated D-Rd versus Rd in 737 patients who were ineligible for high-dose chemotherapy and autologous stem cell transplantation. The primary analysis of MAIA demonstrated a 44% reduction in the risk of disease progression or death after treatment with D-Rd compared with Rd … Read more

Bergenbio Presents Encouraging Updated Preliminary Data From Phase Ii Study In Relapsed Aml Patients At Eha Virtual Meeting

by

BERGEN, Norway, June 11, 2021 /PRNewswire/ — BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, will present updated preliminary survival data from the ongoing Phase II study of bemcentinib (BGBC003) in combination with low dose cytarabine (LDAC) in elderly relapsed Acute Myeloid Leukaemia (AML) patients at the … Read more

OxThera reports results from Phase 3 ePHex study with Oxabact in primary hyperoxaluria patients with maintained kidney function

by

STOCKHOLM, June 11, 2021 /PRNewswire/ — OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces completion of its pivotal Phase 3 study and reports top line results. OxThera’s 52-week OC5-DB-02 study “A Phase III Double-Blind, Randomised Study to Evaluate the Long-Term Efficacy and Safety of Oxabact® … Read more

$ 8.30 Bn growth in Global Forensic Technologies Market 2021-2025 | AB SCIEX LLC, Agilent Technologies Inc., and Cytiva emerge as major players | Technavio

by

NEW YORK, June 11, 2021 /PRNewswire/ — The forensic technologies market is expected to grow by USD 8.30 billion during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of COVID-19 pandemic on the forensic technologies market in optimistic, probable, and pessimistic forecast scenarios. This forensic technologies market report encapsulates not … Read more

With Enhanced Safety and Intelligence Performance, Techking Tires Shine at Changsha International Construction Equipment Exhibition

by

CHANGSHA, China, June 11, 2021 /CNW/ — On May 19th, 2021 (local time), the Changsha International Construction Equipment Exhibition (CICEE 2021) was inaugurated in Changsha, China. During the four-day event, Techking showcased intelligent, customized crane tire solutions and held visitors’ attention, echoing the theme of “Intelligent New Generation Construction Machinery”. According to the organizers, CICEE … Read more

Advertisements